European Patent Classification Number Table


Time interval

1985-2022.12.31


Field display

Table of European Patent Classification Numbers
Patent ID
Classification number category serial number
Classification number
Classification code description

Sample data

Patent ID Classification Number Category Serial Number Classification number Classification number description
EP0000781A3 1 E04B9/28 Connection of slabs, panels, sheets or the like to the supporting construction with the slabs, panels, sheets or the like having grooves engaging with horizontal flanges of the supporting construction or accessory means connected thereto
EP0000187A1 1 F15D1/02 Influencing flow of fluids in pipes or conduits
EP0000187A1 2 F16L55/033 Noise absorbers
EP0000187A1 3 G10K11/161 Methods or devices for protecting against, or for damping, noise or other acoustic waves in general in systems with fluid flow
EP0000364A1 1 A41H37/001 Methods
EP0000364A1 2 A44B1/44 Buttons adapted for special ways of fastening with deformable counterpiece
EP0000581A3 1 G03G5/0585 Cellulose and derivatives
EP0000581A3 2 G03G5/102 Bases for charge-receiving or other layers consisting of or comprising metals
EP0000791A3 1 C08B37/0051 Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
EP0000791A3 2 A61K39/35 Allergens
EP0000791A3 3 A61K39/385 Haptens or antigens, bound to carriers
EP0000791A3 4 A61K2039/6012 Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
EP0000103A1 1 G01N33/76 Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
EP0000103A1 2 A61K39/0006 Contraceptive vaccins; Vaccines against sex hormones
EP0000103A1 3 C07K14/59 Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
EP0000103A1 4 C07K16/26 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones; against hormone releasing or inhibiting factors
EP0000103A1 5 A61K39/00 Medicinal preparations containing antigens or antibodies
EP0000238A1 1 C01B3/30 Production of hydrogen or of gaseous mixtures containing a substantial proportion of hydrogen by decomposition of gaseous or liquid organic compounds of hydrocarbons using moving solid particles using the fluidised bed technique
EP0000238A1 2 C10G2400/26 Fuel gas
EP0000337A1 1 C02F5/12 Treatment of water with complexing chemicals or other solubilizing agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances containing nitrogen
EP0000337A1 2 C23F11/173 Macromolecular compounds
EP0000392A3 1 C07D231/12 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
EP0000392A3 2 A61P31/04 Antibacterial agents
EP0000392A3 3 C07D277/48 Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
EP0000392A3 4 C07D277/587 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m > = 0, Z being a singly or a doubly bound hetero atom
EP0000392A3 5 C07D307/54 Radicals substituted by carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
EP0000392A3 6 C07D499/00 Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3- condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
EP0000481A1 1 A41H37/10 Setting buttons
EP0000619A1 1 H01B3/22 Insulators or insulating bodies characterized by the insulating materials; Selection of materials for their insulating or dielectric properties mainly consisting of organic substances liquids, e.g. oils hydrocarbons
EP0000635A1 1 H01H5/20 Energy stored by deformation of elastic members by flexing of blade springs single blade moved across dead-centre position
EP0000781A2 1 E04B9/28 Connection of slabs, panels, sheets or the like to the supporting construction with the slabs, panels, sheets or the like having grooves engaging with horizontal flanges of the supporting construction or accessory means connected thereto
EP0000794B1 1 B60T15/046 Driver's valves controlling service pressure brakes in multiple circuit systems, e.g. dual circuit systems with valves mounted in tandem
EP0000806B1 1 B60T11/326 Automatic cut-off valves for defective pipes in pneumatic systems
EP0000074A1 1 C07D471/08 Bridged systems
EP0000074A1 2 A61P9/06 Antiarrhythmics
EP0000159A1 1 C07C29/88 Separation; Purification; Use of additives, e.g. for stabilization by treatment giving rise to a chemical modification of at least one compound
EP0000159A1 2 C07C29/74 Separation; Purification; Use of additives, e.g. for stabilisation
EP0000159B1 1 C07C29/88 Separation; Purification; Use of additives, e.g. for stabilization by treatment giving rise to a chemical modification of at least one compound
EP0000159B1 2 C07C29/74 Separation; Purification; Use of additives, e.g. for stabilisation
EP0000191A1 1 E04B2/7411 Details for fire protection

Data update frequency

Annual Update